About Arielle Medford, MD
Dr. Medford obtained her medical degree from the Johns Hopkins University School of Medicine. She completed internal medicine residency at the Massachusetts General Hospital (MGH), where she won several awards including the Harvard Medical School Resident Teaching Award and the MGH Humanism in Medicine Award. She subsequently returned to the MGH to serve as Chief Resident. She completed her medical oncology fellowship at the Dana Farber Cancer Institute/Mass General Cancer Center, where she also became a clinical post-doctoral fellow at the Broad Institute of Harvard & MIT. Her research focuses primarily on the clinical-translational applications of circulating tumor DNA in early and advanced breast cancer, and how these tools can be used to lead to more personalized care for individual patients living with breast cancer. Dr. Medford is a recipient of the Young Investigator Award from the ASCO Conquer Cancer Foundation.
Clinical Interests:
- Breast Cancer
- Circulating Tumor DNA
- Genomics
- Molecular Residual Disease
Treats:
- Adult
Languages:
- Spanish
Locations
Mass General Cancer Center
55 Fruit St.
Boston, MA 02114
Phone: 617-726-5130
Phone: 877-726-5130
Mass General Cancer Center in Danvers
102 Endicott St.
Danvers, MA 01923
Phone: 978-882-6060
Medical Education
- MD, John Hopkins University School of Medicine
- Residency, Massachusetts General Hospital
- Fellowship, Brigham and Women's Hospital
- Fellowship, Dana Farber Cancer Institute
- Fellowship, Massachusetts General Hospital
Publications
-
Medford, A. J., Dubash, T. D., Juric, D., Spring, L., Niemierko, A., Vidula, N., Peppercorn, J., Isakoff, S., Reeves, B. A., LiCausi, J. A., Wesley, B., Malvarosa, G., Yuen, M., Wittner, B. S., Lawrence, M. S., Iafrate, A. J., Ellisen, L., Moy, B., Toner, M., Maheswaran, S., Haber, D.A., Bardia, A. (2019). Blood-based monitoring identifies acquired and targetable driver HER2 mutations in endocrine-resistant metastatic breast cancer. NPJ Precision Oncology, 3, 18.
Medford, A. J., Oshry, L., Boyraz, B., Kiedrowski, L., Menshikova, S., Butusova, A., Dai, C. S., Gogakos, T., Keenan, J. C., Occhiogrosso, R. H., Ryan, P., Lennerz, J. K., Spring, L. M., Moy, B., Ellisen, L. W., & Bardia, A. (2023). TRK inhibitor in a patient with metastatic triple-negative breast cancer and NTRK fusions identified via cell-free DNA analysis. Therapeutic Advances in Medical Oncology, 15, 17588359231152844.
Medford, A. J., Denault, E. N., Moy, B., Parsons, H. A., & Bardia, A. (2023). Circulating Tumor DNA in Breast Cancer: Current and Future Applications. Clinical Breast Cancer.
Medford, A. J., Moy, B., Spring, L. M., Hurvitz, S. A., Turner, N. C., Bardia, A. (2023). Molecular Residual Disease in Breast Cancer: Detection and Therapeutic Interception. Clinical Cancer Research.
Everything excellent!
Nothing everything was great.
She is great
I am receiving fabulous care.
Very professional and caring
Yes, I saw Dr. Medford. She was very thorough. She did keep me waiting for quite a while, but I knew she had an emergency and I totally appreciated the fact that she took the time with the other patient. She was very knowledgeable and I believe answered all of my questions. I had no issues at all with her.
Dr. Medford was patient, kind, and caring. She took the time to talk to me about all of my concerns and helped answer all of the questions that I had. She was phenomenal and was able to give me a lot of different options and feedback, which helped me make better decisions. I would recommend her 100%.
Yes, the doctor is always personable and professional. Every time I talk to her, every time I see her, I come out of the doctor's office very satisfied. Thank you.
Dr. Medford was lovely. I appreciated her warmth and thoroughness.
Dr Medford is a caring and dedicated professional. Her pleasant bedside manor always puts me at ease.